Examining the Pathological Diagnostic Impact of Frozen Sections in Breast Cancer

Abstract

Objective: To analyze the diagnostic value of frozen section pathology in the diagnosis of breast cancer. Methods: A total of 50 patients with breast tumors treated between July 2021 and February 2023 were randomly selected as samples. Both paraffin section and frozen section diagnoses were conducted. The paraffin section results served as the gold standard for evaluating the value of frozen section examination. Results: Among the frozen section diagnoses, 48 cases (96.00%) were confirmed, 1 case was misdiagnosed (2.00%), and 1 case was delayed (2.00%). Among the confirmed patients, 45 cases (90.00%) were entirely consistent, and 3 cases (6.00%) were basically consistent. The diagnostic rate of the frozen section was 96.00%, compared with 100.00% for the paraffin section (P > 0.05). The diagnostic time of the frozen section (35.25 ± 2.11 min) was significantly shorter than that for the paraffin section (6911.36 ± 58.36 min; P < 0.05). Conclusion: Frozen section diagnosis is rapid and demonstrates relatively high diagnostic accuracy. It can guide doctors in determining whether to pursue breast-conserving treatment and aid in selecting appropriate surgical methods. This is beneficial for preventing unnecessary medical interventions and reducing the need for secondary surgeries in breast cancer patients.